Figure 2.
Cumulative incidence of aGVHD at day 100, cGVHD at 12 months, and GVHD relapse-free survival, relapse-free survival, nonrelapse mortality, and overall survival at 36 months. Kaplan-Meier plots of aGVHD (A) and cGVHD (B), GVHD relapse-free survival (C), relapse-free survival (D), nonrelapse mortality (E), and overall survival (F) are presented. CIs shown are 90% intervals.

Cumulative incidence of aGVHD at day 100, cGVHD at 12 months, and GVHD relapse-free survival, relapse-free survival, nonrelapse mortality, and overall survival at 36 months. Kaplan-Meier plots of aGVHD (A) and cGVHD (B), GVHD relapse-free survival (C), relapse-free survival (D), nonrelapse mortality (E), and overall survival (F) are presented. CIs shown are 90% intervals.

Close Modal

or Create an Account

Close Modal
Close Modal